Injunction Against Pfizer's Exubera Tossed Out
U.S. District Judge Leonard B. Sands’ ruling came in the context of Novo Nordisk’s patent suit against Pfizer, which was filed in August. The suit accuses Pfizer of infringing five patents dealing with insulin through its sales of Exubera as a treatment for diabetes.
Novo Nordisk is still looking forward to a trial on...
To view the full article, register now.